about
An update on the diagnosis and treatment of Parkinson diseaseTechnology-aided leisure and communication: Opportunities for persons with advanced Parkinson's disease.Efficacy and safety of Tai Chi for Parkinson's disease: a systematic review and meta-analysis of randomized controlled trialsIs X-linked methyl-CpG binding protein 2 a new target for the treatment of Parkinson's diseaseEryptosis as a marker of Parkinson's diseaseAn animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease.Betaine protects cerebellum from oxidative stress following levodopa and benserazide administration in ratsCurrent Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease.Unwanted effects and interaction of intrajejunal levodopa/carbidopa administration.Astrocytic modulation of blood brain barrier: perspectives on Parkinson's disease.Berberine chloride pretreatment exhibits neuroprotective effect against 6-hydroxydopamine-induced neuronal insult in rat.Carnosine exerts neuroprotective effect against 6-hydroxydopamine toxicity in hemiparkinsonian rat.Altered cytotoxicity of ROS-inducing compounds by sodium pyruvate in cell culture medium depends on the location of ROS generation.Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?Glucose-6-phosphatase-α participates in dopaminergic differentiation.Beneficial antioxidant properties of betaine against oxidative stress mediated by levodopa/benserazide in the brain of rats.Neuroprotective Effect of Coptis chinensis in MPP[Formula: see text] and MPTP-Induced Parkinson's Disease Models.
P2860
Q30243899-34A8DA4E-141E-40EB-986F-6B92685AC217Q30373261-601C1286-7AA3-490C-8818-25F9329B23C6Q33753491-0A20AF8A-6667-42CD-BBA8-C1CD31CBC199Q34094521-4293BF0E-6512-44CC-AD82-2F81AB6FB536Q34585744-C9DAFC43-257B-4F63-80BA-F46D54A9A41EQ35057159-53F9A606-8D4F-493F-BB13-5952A6912D1AQ36391866-4019484B-4209-4B4B-91AC-231093668B41Q36925905-0582ECC0-0604-4AA5-A1A9-4465A73703F3Q38194569-D858239C-9696-4ADE-ADD2-77EA2966C3C2Q38241183-436E0023-D5CF-49DD-B782-4DD69E34C15CQ39179414-84D855E1-D346-40CD-8E47-A4549CF30676Q39205347-2F559F70-022F-4980-8F1D-F218C48CE4C0Q40820830-168ED54A-63F0-4078-8A9B-A98730AB3592Q47652358-4F625168-3B89-4876-87A2-5F36201F0DBFQ47922279-E9F75FAC-BE50-414C-A2AC-186FBF0A91ADQ48337118-C016D101-9244-48B5-80E8-10D9E2AC377EQ53064509-0907FF61-01D8-4872-AF3D-974154A04A3E
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Treatment of Parkinson's disease in the advanced stage.
@ast
Treatment of Parkinson's disease in the advanced stage.
@en
type
label
Treatment of Parkinson's disease in the advanced stage.
@ast
Treatment of Parkinson's disease in the advanced stage.
@en
prefLabel
Treatment of Parkinson's disease in the advanced stage.
@ast
Treatment of Parkinson's disease in the advanced stage.
@en
P2860
P921
P1476
Treatment of Parkinson's disease in the advanced stage.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00702-013-1008-Y
P577
2013-03-10T00:00:00Z
2013-04-01T00:00:00Z